Medical · California, Colorado, Washington · 3 minutes ago
A Psychology Today commentary argues that commercial marijuana legalization has drifted far from its medical roots. It says today's high-potency products raise psychosis and cannabis use disorder risks, and that heavy users drive sales. It also cites an estimated $29.1 billion in 2025 US legal sales and compares the cannabis industry's marketing and lobbying to Big Tobacco's. Marijuana legalization is the focus.
Why it matters: The commentary reflects a growing public health argument that legal cannabis is a commercial product, not a medicine. For consumers and patients, it highlights the gap between dispensary products and tested medicines, and the potency trend. It also signals continued pressure for tighter marketing, potency and warning rules, though it is an opinion piece rather than a policy change.
Read moreSource: psychologytoday.com
Products · California · November 18, 2026
Cannabis cocktail parties are catching on in San Francisco, where Herbal Cocktail Co. staged a Moulin Rouge-themed event called Herbal Rouge. Guests sipped 2 mg THC mocktails, watched burlesque and sampled flower through vaporizers. Co-owner Jamie Evans says low-dose drinks give curious newcomers a sociable way into cannabis.
Why it matters: Low-dose THC drinks at 2 mg are pitched as a gentle, social entry point rather than a smoking session. For consumers, cannabis cocktail parties show where the beverage category is heading: themed events, trained bartenders and flavor-focused menus. Operators say dosing and taste questions remain, so newcomers are still sorting out what to expect from a cannabis cocktail.
Read moreSource: GreenState
Products · California, Massachusetts, New York · November 17, 2026
A High Times analysis by Vee Popat, a dispensary marketing specialist, finds that Google's dispensary rankings mostly reward proximity, complete listings and large review counts. Of 30 map spots in 10 U.S. cities, 20 went to shops with over 1,000 reviews. Several top-rated shops barely appeared, and some Ontario map listings could not be matched to licensing records.
Why it matters: A top Google result says a shop is nearby, has a tidy listing and has gathered many reviews. It says nothing about product freshness, staff knowledge or prices. In Ontario, a perfect rating was no proof of a license. Shoppers who want to confirm legitimacy are better served by official license lookups than by star ratings.
Read moreSource: High Times
Laws · California · November 17, 2026
A California lawsuit accuses Los Angeles dispensary LAX CC of embedding "spy pixels" in marketing emails. The plaintiff claims the code invaded their privacy under California law and fed data to brokers, tracking details like when emails are opened, location and forwarding.
Why it matters: If the claims hold up, a dispensary's marketing emails could be quietly collecting data on customers, including when they read messages and where they are. For shoppers, it raises questions about what retailers learn from sign-ups. These are allegations only, and no ruling has been made.
Read moreSource: WeedWeek